RCT | Empagliflozin in acute myocardial infarction accompanied by a large creatine kinase elevation.
25 Oct, 2022 | 13:11h | UTCEmpagliflozin in acute myocardial infarction: the EMMY trial – European Heart Journal
Commentary on Twitter
News from EMMY trial: in myocardial infarction, empagliflozin improves NT-proBNP and left ventricular ejection fraction! https://t.co/92WUJRbKuG#myocardial #infarction #empaglifozin #ehj #cardiotwitter @ESC_Journals @escardio pic.twitter.com/XPwowjZrlf
— EHJ Editor-in-Chief (@ehj_ed) September 16, 2022